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Introduction
Renal oncocytoma was first described in 1942 by Zippel
and was grouped into renal malignancy at that time.1
It was not until 1976 that it was accepted to be a distinct
benign renal tumor with the report of 13 additional
cases by Klein and Valensi.2 The current 2004 World
Health Organization classification of renal epithelial
tumors recognizes benign lesions such as oncocytoma
and angiomyolipoma.3 Oncocytomas are characterized
by uniform polygonal or round cells with mitochondria-
rich eosinophilic granular cytoplasm that occur in diffuse
sheets or as islands of cells in an edematous stroma.3
The cells of origin are thought to be the intercalated
cells in the collecting duct.4 They account for 3–7% of
all solid renal neoplasms.5 The majority (58–83%) are
incidental findings on radiologic images from ultra-
sonography, computed tomography (CT) and magnetic
resonance imaging (MRI).6–8 Most often, the diagnosis
of renal oncocytoma is made after surgical removal 
of the tumor because of the lack of specific clinical
features and imaging findings. Moreover, fine needle 
aspiration and biopsy are often not diagnostic due to
oncocytoma having similar histopathologic character-
istics as various eosinophilic variants of renal cell carci-
noma (RCC).9 Consequently, most patients with these
tumors are treated aggressively with either partial or
radical nephrectomy.
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Renal oncocytoma has been reported mostly in
the Western literature, and only a few cases have been
reported in Eastern populations.10–12 In the present
study, we review the clinical course of renal oncocytoma
in our institution.
Methods
A total of 13 cases of renal oncocytoma, diagnosed
between January 1988 and June 2006, were retrieved
from the surgical pathological archives at our hospital.
In this retrospective chart-review study, clinicopatho-
logic data including patient characteristics, clinical man-
ifestations, surgical technique, pathologic findings and
clinical outcome were analyzed.
Tumor size was evaluated by measuring the largest
diameter of the tumor mass removed surgically. Tumor
growth patterns were classified as exophytic or non-
exophytic, and non-exophytic growth pattern was fur-
ther subcategorized as with or without renal sinus
involvement.
Results
The demographic and clinical features of the patients are
shown in Table 1. There were 10 males and 3 females
(male/female ratio of 3.3); mean age at presentation
was 59.6 years (range, 37–75 years). Of the 13 cases,
12 (92.3%) were diagnosed incidentally as renal tumor
by sonography (n = 9), CT (n = 1) or MRI (n = 2), and
1 presented with microscopic hematuria. Preoperatively,
the clinical impression of oncocytoma had been con-
sidered in only 3 (23.1%) patients following various
imaging studies. Among them, 2 underwent CT which
showed a centrally located stellate area of low attenu-
ation (Figure 1), and the other underwent MRI which
revealed a centrally located stellate area of low signal
intensity on T1-weighted imaging. Most patients
(76.9%) were suspected to have RCC and were treated
accordingly. Ten (76.9%) patients underwent radical
nephrectomy, 2 (15.4%) underwent partial nephrec-
tomy and 1 (7.7%) received excisional biopsy. Radical
nephrectomy was performed with the open method
in 8 patients and laparoscopically in 2 patients.
The tumor location was right-sided in 7 (53.8%)
cases and left-sided in 6 (46.2%). No bilateral or mul-
tifocal disease was observed. CT or MRI images were
available for 10 patients; an exophytic growth pattern
was noted in 2 cases and non-exophytic growth pattern
was noted in 8, including 3 without and 5 with renal
sinus involvement. Tumor size ranged from 2.7 cm to
8.5 cm in greatest dimension (< 4 cm in 6 patients,
≥ 4 cm in 7 patients), with a mean tumor size of 5.3 cm.
Most of the pathologic features of the tumors in our
series were those of typical oncocytoma, i.e. oncocytes
arranged in trabecular, acinar and glandular patterns.
However, there was 1 patient who was initially diag-
nosed with chromophobe RCC; this diagnosis was
revised to oncocytoma after further immunohistochem-
istry study with a panel of cytokeratin staining profiles
(cytokeratin 7). In addition, the coexistence of onco-
cytoma and angiomyolipoma in the same lesion was
noted in 1 case. No extension to perinephric fat tissue
or lymphovascular invasion was observed.
Excluding the 3 patients who were lost to follow-up,
there was neither recurrence nor death from oncocy-
toma during a mean follow-up of 53.2 months (range,
10–117 months). Accordingly, the disease-specific sur-
vival was 100%.
Discussion
Renal oncocytomas occur with an overall incidence of
3–7% among all renal tumors. Most (56–91%) are diag-
nosed incidentally, but symptomatic patients usually
manifest with gross hematuria, flank pain or a palpable
mass.13 The male/female predominance is 2–3:1, and
peak occurrence is between the ages of 40 and 60.
Average tumor size is 6 cm. In our series, the mean
age at diagnosis was 59.6 years, and there was a male
predilection with a male-to-female ratio of 3.3. Most
Table 1. Demographic characteristics and clinical features of the
patients*
Sex
Male 10 (76.9)
Female 3 (23.1)
Presentation
Incidental 12 (92.3)
Symptomatic 1 (7.7)
Laterality
Right 7 (53.8)
Left 6 (46.2)
Surgery
Radical nephrectomy 10 (76.9)
Partial nephrectomy 2 (15.4)
Excisional biopsy 1 (7.7)
Size
< 4 cm 6 (46.2)
≥ 4 cm 7 (53.8)
*Data presented as n (%).
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patients presented with renal tumor incidentally except
for 1 with hematuria. The mean tumor size was 5.3 cm.
The demographic characteristics of our population, in-
cluding gender distribution, peak occurrence, tumor
size and clinical symptoms, are similar to the findings of
previous studies. Moreover, the demographics of onco-
cytoma parallel those of RCC.14 Accordingly, clinical
features cannot be used to discriminate oncocytoma
from RCC.
The minimally invasive nature of imaging studies
makes such techniques ideal for diagnosing benign
tumors. However, no radiologic imaging techniques are
currently available to reliably confirm a preoperative
diagnosis of oncocytoma. CT usually reveals a solid
homogeneous lesion with a centrally located stellate
area of low attenuation. On MRI, most oncocytomas
demonstrate low signal intensity relative to the renal
cortex on T1-weighted images. Twenty-seven percent
of oncocytomas also demonstrate a central stellate scar
on MRI.15 Angiography shows a spoke-wheel vascular
pattern, but inconsistently. The degree of confidence
with angiography is low. Hypovascular lesions may
result in false-negative results, and hypervascular lesions
may mimic RCCs. In our series, 2 patients presented
with typical CT findings and 1 with typical MRI finding.
However, these characteristics may suggest but cannot
definitively diagnose oncocytoma.16,17 Gormley et al
reported that the nuclear agent, technetium sestamibi,
which was remarkably retained in mitochondria, showed
increased uptake by oncocytomas compared to other
renal lesions including RCC, angiomyolipoma and
cysts.18 MR spectroscopy has been demonstrated to
reveal different spectrographic signals from oncocy-
toma compared to RCC.19 Currently, few articles have
reported the use of positron emission tomography
(PET) for the diagnosis of oncocytoma. Blake et al
reported a case of renal oncocytoma displaying intense
activity on 18F-fluorodeoxyglucose PET.20 It might be
hypothesized that a benign tumor would behave met-
abolically differently from a malignant tumor, result-
ing in differential 18F-fluorodeoxyglucose uptake. Shriki
et al described the first report of the 1-11C acetate
PET scan appearance of a renal oncocytoma. Possible
mechanisms for increased uptake include dysfunctional
but upregulated oxidative phosphorylation, or uptake
through lipid biosynthesis pathways.21 All the novel
imaging techniques were investigational, and further
validated studies are required.
In our series, 1 patient was diagnosed with chromo-
phobe renal cell carcinoma initially, which was revised to
oncocytoma after further analysis of cytokeratin stain-
ing profiles. Differentiating oncocytoma from RCC
histologically can be difficult, especially from chro-
mophobe RCC, which originates from intercalated
cells of the kidney tubules as well.22 The most common
microscopic feature shared by oncocytomas and chro-
mophobe RCC is the presence of abundant granular
eosinophilic cells.23 Oncocytomas mainly consist of 
eosinophilic cells arranged in an organoid, tubulocystic
or mixed pattern; chromophobe RCC are always com-
prised of two cell types, with one type consisting of
abundant eosinophilic cytoplasm and the other contain-
ing abundant, clear, and finely reticulated cytoplasm,
which are arranged in diffuse sheets of cells aligned
along fibrovascular septae.24 Unlike the round and uni-
form nuclei typical of oncocytomas, chromophobe
A
B
Figure 1. (A) Pelvic computed tomography, axial view, shows a
right renal tumor with central stellate scar. (B) Pelvic computed
tomography, coronal view, shows a right renal tumor with central
stellate scar and renal sinus involvement.
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RCC are significantly more likely to have irregular
nuclear contour with bi- or multinucleation. With re-
gard to Hales’s colloidal iron stain, chromophobe RCC
show strong diffuse positivity and oncocytoma show
negative or weak focal staining. Recent data proposed
that cytokeratin staining profiles may be useful for
discriminating oncocytoma from its renal mimics: on-
cocytomas are typically CD7–, CD14+ and CD20+,
while most chromophobe RCCs are positive for CD7;
the various eosinophilic RCC are typically negative
for CD14, and only 0–8% of RCCs are positive for
CD20.25–27
The finding of frequent coexistence of oncocytoma
and chromophobe RCC is interesting,28 suggesting a
potential relation between these entities. In addition,
both originate from the tubular intercalated cells and
share common histologic findings. There is growing
evidence that oncocytomas represent the benign end
of a spectrum and chromophobe RCCs reside at the
malignant end.29 The phenomenon of renal oncocy-
toma with an increased risk of chromophobe RCC has
only been described in Birt-Hogg-Dube syndrome,
which is grouped as familial renal oncocytoma. This
syndrome is a rare autosomal dominant condition char-
acterized by benign skin tumors, pulmonary cysts and
multiple renal tumors, particularly oncocytomas and
chromophobe RCC,30 resulting from the mutation of
the Birt-Hogg-Dube gene on the short arm of chromo-
some 7.31 In this syndrome, oncocytomas are usually
multifocal and bilateral.
The coexistence of oncocytoma and angiomy-
olipoma in the same lesion was noted in 1 case. Under
the preoperative impression of oncocytoma, this male
patient received excisional biopsy, and pathology re-
vealed concurrent oncocytoma and angiomyolipoma.
Although concurrence of RCC and oncocytoma within
the same kidney is well recognized, the simultaneous
existence of angiomyolipoma and oncocytoma is un-
common. To our knowledge, only 17 cases of con-
current angiomyolipoma and oncocytoma have been
reported in the literature, and most of the patients
were female.32,33 This observation parallels the female
predominance of angiomyolipoma as opposed to the
male predominance of oncocytoma. The mechanisms
that cause a kidney to possess concurrent angiomy-
olipoma and oncocytoma are unclear at present.
The natural history of oncocytomas follows a benign
and usually slow-growing course despite the occasional
presence of invasive features such as lymphovascular
and perinephric fat tissue involvement. Accordingly,
conservative surgery, even for large tumors, should be
performed, and the limit of conservative surgery is
only technical.34 In our series, most patients (76.9%)
underwent radical nephrectomy, which might be con-
sidered over-treatment. Because of the uncertainties
with regard to the benign nature of the tumor before
surgical intervention, radical nephrectomy was war-
ranted in most patients. Currently, nephron-sparing
surgery has been recommended as the standard of care
for renal oncocytoma,35 and is also considered the treat-
ment of choice for cT1 clinically localized renal cell
carcinoma.36,37
In conclusion, renal oncocytoma behaves as a be-
nign tumor, and the long-term prognosis is excellent.
Nephron-sparing surgery is the mainstay of treatment,
especially for patients with small tumors. However, as
accurate preoperative diagnosis based on imaging stud-
ies was difficult, radical nephrectomy was warranted
for most of the patients in our series.
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